Neuland Laboratories' Stock Sees 3.21% Increase, Hits 52-Week High on Strong Market Performance
Neuland Laboratories, a leading pharmaceutical company, has seen a 3.21% increase in its stock price on November 28, 2024. The company's strong performance and market trends have led to a 'Hold' call from MarketsMojo. The stock has hit a new 52-week and all-time high, outperforming the sector and Sensex, making it a promising investment option.
Neuland Laboratories, a leading pharmaceutical company in the largecap industry, has seen a 3.21% increase in its stock price on November 28, 2024. This rise in stock price has been attributed to the company's strong performance in the market.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Neuland Laboratories' stock is 'Hold'. This is based on the company's recent performance and market trends.
The stock has also hit a new 52-week and all-time high of Rs. 16666 on the same day. This is a significant milestone for the company and reflects its strong growth potential.
In today's trading, Neuland Laboratories has outperformed the sector by 2.78%. This is a positive sign for investors and indicates the company's strong position in the market.
The stock has been on a consecutive gain for the last 3 days, with a 10.71% increase in returns during this period. This shows the company's consistent growth and stability in the market.
Neuland Laboratories' stock touched an intraday high of Rs. 16666, a 3.74% increase from the previous day. This further reinforces the company's strong performance and market position.
In terms of moving averages, Neuland Laboratories is trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock and reflects its strong market performance.
Compared to the Sensex performance, Neuland Laboratories' stock has outperformed with a 1-day performance of 3.40% while the Sensex has seen a -0.83% decrease. Similarly, in the last 1 month, the company's stock has outperformed the Sensex with a 19.66% increase compared to the Sensex's -0.54% performance.
Overall, Neuland Laboratories has shown strong performance in the market, with a consistent increase in stock price and outperforming the sector and Sensex. This makes it a promising investment option for investors in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
